FlippingFood III 2021

Enfermedades gastrointestinales

Parada A, Araya M. El gluten. Su historia y efectos en la enfermedad celíaca. Rev Med Chile 2010; 138: 1319-1325. https://www.scielo.cl/scielo.php?script=sci_ arttext&pid=S0034-98872010001100018 Pejcz E, Spychaj R, Gil Z. Technological methods for reducing the content of fructan in wheat bread. Foods 2019; 8: 663. https://doi.org/10.3390/foods8120663 Ratziu V, Ghabril M, Romero-Gomez M, Svegliati-Baroni G. Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis. Transplantation 2019; 103:28- 38. https://doi.org/10.1016/10.1097/TP.0000000000002483 Silvester JA, Comino I, Kelly CP, Sousa C, Duerksen DR. Most patients with celiac disease on gluten- free diets consume measurable amounts of gluten. Gastroenterology 2020; 158:1497–1499. http://dx.doi. org/10.1053/j.gastro.2019.12.016 Tuck C, Barrett J. Re-challenging FODMAPs: the low FODMAP diet phase two. J Gastroenterol Hepatol 2017; 32: 11–15. http://dx.doi.org/10.1111/jgh.13687 Tuck C, Ly E, Bogatyrev A, Costetsou I, Gibson P, Barrett J, Muir J. Fermentable short chain carbohydrate (FODMAP) content of common plant-based foods and processed foods suitable for vegetarian- and vegan-based eating patterns. J Hum Nutr Diet. 2018; 31: 422–435. http://dx.doi.org/10.1111/jhn.12546 Tumani MF, Pavez C, Parada A. Microbiota, hábitos alimentarios y dieta en enfermedad inflamatoria intestinal. Rev Chil Nutr 2020; 47(5 ): 822-829. https://www. scielo.cl/scielo.php?script=sci_arttext&pid=S0717- 75182020000500822&lang=pt

Varney J, Barrett J, Scarlata K, Catsos P, Gibson PR, Muir JG. FODMAPs: Food composition, defining cutoff values and international application. J Gastroenterol Hepatol 2017; 32: 53–61. http://dx.doi.org/10.1111/jgh.13698 Whelan K, Martin LD, Staudacher HM, Lomer MCE. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet 2018; 31: 239–255. http:// dx.doi.org/10.1111/jhn.12530 Whigham L, Joyce T, Harper G, Irving PM, Staudacher HM, Whelan K, Lomer MCE. Clinical effectiveness and economic costs of group versus one-to-one education for shortchain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. J Hum Nutr Diet. 2015; 28: 687–696 http:// dx.doi.org/10.1111/jhn.12318 Yu J, Shen J, Sun TT, Zhang X, Wong N. Obesity, insulin resistance, NASH and hepatocellular carcinoma. Semin Cancer Biol 2013; 23 (supl. 6): 483-91. https://doi. org/10.1016/j.semcancer.2013.07.003 Zelber-Sagi S, Godos J, Salomone F. Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. Therap Adv Gastroenterol 2016; 9: 392–407. https://doi. org/10.1177/1756283X16638830

31